Quick Answer
Upstream Bio, Inc. reported Total Assets of $353.77 million for fiscal year 2025.
Upstream Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $353.77M | -26.6% |
| 2024 | $481.72M | +311.0% |
| 2023 | $117.20M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $391.19M | +68.1% | -7.0% |
| June 30, 2025 | $420.52M | — | -7.8% |
| March 31, 2025 | $456.17M | — | -5.3% |
| December 31, 2024 | $481.72M | +311.0% | +107.0% |
| September 30, 2024 | $232.70M | — | +98.6% |
| December 31, 2023 | $117.20M | — | — |
- Upstream Bio, Inc. showed a decrease of -26.6% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Upstream Bio, Inc.’s total assets has grown by 201.9% (from $117.20 million to $353.77 million).
- The most recent figure is from Upstream Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: